Publications

5808 Results

Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma: A Southwest Oncology Group study.

Authors
RL Martino;TR Fleming;LM Morrell;B Ardalan;SP Richman;JS Macdonald
Journal / Conference
Investigational New Drugs 14:419-421
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8734

Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: A Phase I/II Southwestern Oncology Group study.

Authors
AB Einstein Jr;M Wolf;KR Halliday;GJ Miller;M Hafermann;BA Lowe;FJ Meyers;JT Leimert;ED Crawford
Journal / Conference
Urology 47(5):652-657
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8704

Phase III study of IP cisplatin plus IV cyclophosphamide vs IV cisplatin plus IV cyclophosphamide in optimal disease stage III ovarian cancer: An Intergroup study 0051 (SWOG-GOG-ECOG).

Authors
DS Alberts;PY Liu;EV Hannigan;R O'Toole;SD Williams;J Young;EW Franklin;D Clarke-Pearson;VK Malviya;B DuBeshter;W Hoskins;M Adelson;RD Alvarez;S Vogel;J O'Sullivan;DJ Garcia;D Sparks;ML Rothenberg
Journal / Conference
Society of Gynecologic Oncologists Abstract Book (#1):40
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8501 (INT-0051)

Evaluation of race as a prognostic factor in multiple myeloma: An ancillary of Southwest Oncology Group study 8829.

Authors
MR Modiano;P Villar-Werstler;J Crowley;SE Salmon
Journal / Conference
Journal of Clinical Oncology 14(3):974-977
Year
1996
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group (SWOG-8921).

Authors
LE Flaherty;PY Liu;MS Mitchell;WS Fletcher;MJ Walker;JW Goodwin;RL Stephens;VK Sondak
Journal / Conference
American Journal of Clinical Oncology 19(2):108-113
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8921

Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group.

Authors
RA Figlin;JJ Crowley;EL Jacobs;M Muirhead;JW Goodwin;JJ Rinehart;RB Livingston
Journal / Conference
Cancer 78(5):998-1003
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-9127

GM-CSF did not allow doxorubicin dose escalation in the maid regimen: A phase I trial. A Southwest Oncology Group study

Authors
LG Hicks;SP Balcerzak;M Zalupski
Journal / Conference
Cancer Investigation 14(6):507-512
Year
1996
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8922

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.

Authors
SK Williamson;MK Wolf;MA Eisenberger;MA O'Rourke;W Brannan;ED Crawford
Journal / Conference
American Journal of Clinical Oncology (CCT) 19(4):368-370
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8719

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;J O'Sullivan;AB Cruz;MD Abeloff;WR Jewell;JJ Costanzi;WB Farrar;CK Osborne
Journal / Conference
Journal of Clinical Oncology 14(1):46-51
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Intraperitoneal mitoxantrone or floxuridine: Effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy-A randomized phase II study by the Southwest Oncology Group.

Authors
FM Muggia;PY Liu;DS Alberts;DL Wallace;RV O'Toole;KY Terada;EW Franklin;GW Harrer;DA Goldberg;EV Hannigan
Journal / Conference
Gynecologic Oncology 61:395-402
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8835